Literature DB >> 25085354

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.

Vissal David Kheav1, Marc Busson2, Catherine Scieux3, Régis Peffault de Latour4, Guitta Maki5, Philippe Haas1, Marie-Christine Mazeron3, Maryvonnick Carmagnat5, Emeline Masson5, Aliénor Xhaard6, Marie Robin6, Patricia Ribaud6, Nicolas Dulphy1, Pascale Loiseau7, Dominique Charron8, Gérard Socié9, Antoine Toubert10, Hélène Moins-Teisserenc10.   

Abstract

Natural killer cells are the first lymphocyte subset to reconstitute, and play a major role in early immunity after allogeneic hematopoietic stem cell transplantation. Cells expressing the activating receptor NKG2C seem crucial in the resolution of cytomegalovirus episodes, even in the absence of T cells. We prospectively investigated natural killer-cell reconstitution in a cohort of 439 adult recipients who underwent non-T-cell-depleted allogeneic hematopoietic stem cell transplantation between 2005 and 2012. Freshly collected blood samples were analyzed 3, 6, 12 and 24 months after transplantation. Data were studied with respect to conditioning regimen, source of stem cells, underlying disease, occurrence of graft-versus-host disease, and profiles of cytomegalovirus reactivation. In multivariate analysis we found that the absolute numbers of CD56(bright) natural killer cells at month 3 were significantly higher after myeloablative conditioning than after reduced intensity conditioning. Acute graft-versus-host disease impaired reconstitution of total and CD56(dim) natural killer cells at month 3. In contrast, high natural killer cell count at month 3 was associated with a lower incidence of chronic graft-versus-host disease, independently of a previous episode of acute graft-versus-host disease and stem cell source. NKG2C(+)CD56(dim) and total natural killer cell counts at month 3 were lower in patients with reactivation of cytomegalovirus between month 0 and month 3, but expanded greatly afterwards. These cells were also less numerous in patients who experienced later cytomegalovirus reactivation between month 3 and month 6. Our results advocate a direct role of NKG2C-expressing natural killer cells in the early control of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2014        PMID: 25085354      PMCID: PMC4258747          DOI: 10.3324/haematol.2014.108407

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  47 in total

1.  Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

Authors:  K Hadaya; C de Rham; C Bandelier; C Bandelier; S Ferrari-Lacraz; S Jendly; T Berney; L Buhler; L Kaiser; J D Seebach; J M Tiercy; P Y Martin; J Villard
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

2.  An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

Authors:  Nicolas Dulphy; Philippe Haas; Marc Busson; Stéphanie Belhadj; Régis Peffault de Latour; Marie Robin; Maryvonnick Carmagnat; Pascale Loiseau; Ryad Tamouza; Catherine Scieux; Claire Rabian; James P Di Santo; Dominique Charron; Anne Janin; Gérard Socié; Antoine Toubert
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

Review 3.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

Authors:  K M Sullivan; E Agura; C Anasetti; F Appelbaum; C Badger; S Bearman; K Erickson; M Flowers; J Hansen; T Loughran
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

4.  Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.

Authors:  N Tormo; C Solano; I Benet; M A Clari; J Nieto; R de la Cámara; J López; N López-Aldeguer; J C Hernández-Boluda; M J Remigia; A Garcia-Noblejas; C Gimeno; D Navarro
Journal:  Bone Marrow Transplant       Date:  2009-07-20       Impact factor: 5.483

5.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

6.  Spotlight on NKG2C and the human NK-cell response to CMV infection.

Authors:  Karl-Johan Malmberg; Vivien Beziat; Hans-Gustaf Ljunggren
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

7.  Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Hélène Moins-Teisserenc; Marc Busson; Catherine Scieux; Véronique Bajzik; Jean-Michel Cayuela; Emmanuel Clave; Régis Peffault de Latour; Félix Agbalika; Patricia Ribaud; Marie Robin; Vanderson Rocha; Eliane Gluckman; Dominique Charron; Gérard Socié; Antoine Toubert
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

8.  The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  Viruses       Date:  2009       Impact factor: 5.048

9.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

10.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

View more
  23 in total

1.  Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.

Authors:  Letizia Muccio; Alice Bertaina; Michela Falco; Daniela Pende; Raffaella Meazza; Miguel Lopez-Botet; Lorenzo Moretta; Franco Locatelli; Alessandro Moretta; Mariella Della Chiesa
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

2.  Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Authors:  Raphael Itzykson; Marie Robin; Helene Moins-Teisserenc; Marc Delord; Marc Busson; Aliénor Xhaard; Flore Sicre de Fontebrune; Régis Peffault de Latour; Antoine Toubert; Gérard Socié
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

3.  GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

Authors:  Mark D Bunting; Antiopi Varelias; Fernando Souza-Fonseca-Guimaraes; Iona S Schuster; Katie E Lineburg; Rachel D Kuns; Peter Fleming; Kelly R Locke; Nicholas D Huntington; Bruce R Blazar; Steven W Lane; Siok-Keen Tey; Kelli P A MacDonald; Mark J Smyth; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Blood       Date:  2016-12-07       Impact factor: 22.113

4.  Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study.

Authors:  Xiang-Yu Zhao; Xiao-Su Zhao; Yu-Tong Wang; Yu-Hong Chen; Lan-Ping Xu; Xiao-Hui Zhang; Wei Han; Huan Chen; Yu Wang; Chen-Hua Yan; Feng-Rong Wang; Jing-Zhi Wang; Kai-Yan Liu; Ying-Jun Chang; Xiao-Jun Huang
Journal:  Oncoimmunology       Date:  2016-10-28       Impact factor: 8.110

5.  Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Authors:  Aimee Merino; Bin Zhang; Philip Dougherty; Xianghua Luo; Jinhua Wang; Bruce R Blazar; Jeffrey S Miller; Frank Cichocki
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

Review 6.  The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.

Authors:  Alireza Zafarani; Mahsa Taghavi-Farahabadi; Mohammad Hossein Razizadeh; Mohammad Reza Amirzargar; Mansoure Mansouri; Mohammad Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-08-22       Impact factor: 6.692

Review 7.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

8.  Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

Authors:  Amina Kariminia; Shernan G Holtan; Sabine Ivison; Jacob Rozmus; Marie-Josée Hebert; Paul J Martin; Stephanie J Lee; Daniel Wolff; Peter Subrt; Sayeh Abdossamadi; Susanna Sung; Jan Storek; Megan Levings; Mahmoud Aljurf; Mukta Arora; Corey Cutler; Geneviève Gallagher; John Kuruvilla; Jeff Lipton; Thomas J Nevill; Laura F Newell; Tony Panzarella; Joseph Pidala; Gizelle Popradi; David Szwajcer; Jason Tay; Cynthia L Toze; Irwin Walker; Stephen Couban; Barry E Storer; Kirk R Schultz
Journal:  Blood       Date:  2016-03-28       Impact factor: 22.113

Review 9.  Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation.

Authors:  Ajit P Limaye; Tara M Babu; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2020-10-28       Impact factor: 26.132

Review 10.  Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Md Ashik Ullah; Geoffrey R Hill; Siok-Keen Tey
Journal:  Front Immunol       Date:  2016-04-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.